Rheumatism Hospital Graasten Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
1998
NCT00209859
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1998

Timeline

NOW
  • Now